Clinical relevance of various microscopical features of the second-look specimen in advanced ovarian cancer.

[1]  G. Fleuren,et al.  Tumor ploidy as a major prognostic factor in advanced ovarian cancer , 1987, Cancer.

[2]  A. Oosterom,et al.  COMPLETE REMISSION AT LAPAROTOMY: STILL A GOLD STANDARD IN OVARIAN CANCER? , 1986, The Lancet.

[3]  G. Malkasian,et al.  Second-look laparotomy in ovarian cancer: evaluation of pathologic variables. , 1985, American journal of obstetrics and gynecology.

[4]  N. Sneige,et al.  Prognosis of surgically determined complete responders in advanced ovarian cancer , 1985, Cancer.

[5]  N. Sneige,et al.  Microscopic disease at second‐look laparotomy in advanced ovarian cancer , 1985, Cancer.

[6]  J. Neijt,et al.  RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMA , 1984, The Lancet.

[7]  N. Hacker,et al.  Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status. , 1984, Obstetrics and gynecology.

[8]  P. Schwartz,et al.  Second-look operations in ovarian cancer. , 1980, American journal of obstetrics and gynecology.

[9]  C. Wilson,et al.  FENFLURAMINE AND DREAMING , 1974 .

[10]  C. Coffin,et al.  The second-look operation for ovarian neoplasms: a study of 85 cases emphasizing cytologic and histologic problems. , 1985, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[11]  G. Rosen,et al.  Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. , 1977, Archives of pathology & laboratory medicine.

[12]  D. Bulmer.  Letter: Anatomy and medicine 1975. , 1975, Lancet.